CASE-CONTROL STUDY OF INTESTINAL PARASITES IN PATIENTS WITH INTESTINAL CANCER IN SOHAG, EGYPT | ||||
| Journal of the Egyptian Society of Parasitology | ||||
| Article 18, Volume 54, Issue 2, August 2024, Page 319-324 PDF (1.72 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jesp.2024.373538 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| NAGWA IBRAHIM SELEEM1; NADA ABD EL-FATTAH EL-NADI1; EMAD ELDIN NABIL HASSAN2; MANAL REYAD GABALLAH1 | ||||
| 1Department of Medical Parasitology, Faculty of Medicine, Sohag University, Egypt | ||||
| 2Department of Clinical Oncology, Faculty of Medicine, Sohag University, Egypt | ||||
| Abstract | ||||
| Significant morbidity and mortality occur in immunocompromised hosts as a result of parasite infections. Cancer patients have impaired immune systems, either due to the illness itself or as a result of immunosuppressive medications or treatments. In this study, parasitic infections in patients with intestinal cancer from Sohag Hospitals and Sohag Oncology Center's Clinical Oncology and Nuclear Medicine department were assessed. Between April and October of 2023, a total of 100 stool samples were taken from outpatient clinics; another 100 stool samples were taken from the healthy control group. Every sample that was gathered was split into three sections: the first was used for microscopic and macroscopic analysis, the second was kept for later use and preservation, and the third was cultivated to identify Strongyloides stercoralis. In contrast to 21% (21 instances) in controls, 45% (45 cases) of patients with intestinal cancers (24 with colon cancer and 21 with rectal cancer) had intestinal parasites. According to the data, Blastocystis hominis was the most prevalent | ||||
| Keywords | ||||
| Blastocystis hominis; cancer; intestinal parasites; and patients | ||||
|
Statistics Article View: 25 PDF Download: 59 |
||||
